iX Biopharma (SGX:42C) Days Sales Outstanding : 82.67 (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is iX Biopharma Days Sales Outstanding?

iX Biopharma's average Accounts Receivable for the six months ended in Dec. 2024 was S$1.68 Mil. iX Biopharma's Revenue for the six months ended in Dec. 2024 was S$3.71 Mil. Hence, iX Biopharma's Days Sales Outstanding for the six months ended in Dec. 2024 was 82.67.

The historical rank and industry rank for iX Biopharma's Days Sales Outstanding or its related term are showing as below:

SGX:42C' s Days Sales Outstanding Range Over the Past 10 Years
Min: 9.21 Med: 51.9 Max: 1296.79
Current: 100.24

During the past 11 years, iX Biopharma's highest Days Sales Outstanding was 1296.79. The lowest was 9.21. And the median was 51.90.

SGX:42C's Days Sales Outstanding is ranked worse than
72.65% of 958 companies
in the Drug Manufacturers industry
Industry Median: 72.25 vs SGX:42C: 100.24

iX Biopharma's Days Sales Outstanding declined from Dec. 2023 (124.75) to Dec. 2024 (82.67).

iX Biopharma Days Sales Outstanding Historical Data

The historical data trend for iX Biopharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iX Biopharma Days Sales Outstanding Chart

iX Biopharma Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Days Sales Outstanding

Get a 7-Day Free Trial

35.94

38.80

9.21

54.14

77.88

iX Biopharma Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Days Sales Outstanding	Get a 7-Day Free Trial															98.04	93.33	124.75	102.60	82.67

Competitive Comparison of iX Biopharma's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, iX Biopharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iX Biopharma's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, iX Biopharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where iX Biopharma's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

iX Biopharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

iX Biopharma's Days Sales Outstanding for the fiscal year that ended in Jun. 2024 is calculated as

	Days Sales Outstanding (A: Jun. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Jun. 2024 ))	/	count )	/	Revenue (A: Jun. 2024 )	*	Days in Period
=	( (1.25	+	1.293)	/	2 )	/	5.959	*	365
=	1.2715					/	5.959	*	365
=	77.88

iX Biopharma's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding (Q: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (1.293	+	2.071)	/	2 )	/	3.713	*	365 / 2
=	1.682					/	3.713	*	365 / 2
=	82.67

iX Biopharma (SGX:42C) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

iX Biopharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of iX Biopharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

iX Biopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » iX Biopharma Ltd (SGX:42C) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

1 Kim Seng Promenade, No. 14-01, Great World City East Lobby, Singapore, SGP, 237994

Website

https://www.ixbiopharma.com

iX Biopharma Ltd is a Singapore-based specialty pharmaceutical and nutraceutical company focused on the development, manufacture, and commercialization of therapies for the treatment of acute and breakthrough pain, and other health conditions. Its products under development are Wafermine and BnoX for pain management, Wafesil for erectile dysfunction, WafeRest for improved sleep quality, and others. Its business segments are Specialty Pharmaceutical and Nutraceutical business segments. The firm's business segments operate in United States of America, Singapore, Australia, and China, of which the majority of the revenue comes from the United States of America. The company generates the majority of its revenue from the sale of specialty pharmaceutical products.

iX Biopharma Headlines

No Headlines